| |
| |
|
| Insider
Information: |
Rosen Howard B |
| Relationship: |
|
| City: |
Mountain View |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
17,780 |
|
|
Indirect Shares
|
165 |
|
|
| Direct
Value |
$93,913 |
|
|
|
Indirect Value
|
$1,168 |
|
|
| Total
Shares |
17,945 |
|
|
| Total
Value |
$95,081 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Acelrx Pharmaceuticals Inc |
ACRX |
Director |
2023-10-10 |
5,293 |
2011-03-02 |
0 |
Premium* |
|
|
Kala Pharmaceuticals, Inc. |
KALA |
|
2023-06-22 |
12,487 |
2023-06-22 |
165 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACRX |
Acelrx Pharmaceuticals In... |
Director |
– • – |
2023-10-10 |
4 |
A |
$0.00 |
$0 |
D/D |
581 |
5,293 |
0 |
- |
|
| KALA |
Kala Pharmaceuticals, Inc... |
|
– • – |
2023-06-22 |
4 |
A |
$0.00 |
$0 |
D/D |
9,088 |
12,487 |
0 |
- |
|
| KALA |
Kala Pharmaceuticals, Inc... |
|
– • – |
2023-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
2,502 |
3,399 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Director |
– • – |
2022-07-15 |
4 |
A |
$0.00 |
$0 |
D/D |
15,500 |
94,250 |
0 |
- |
|
| KALA |
Kala Pharmaceuticals, Inc... |
|
– • – |
2021-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
44,824 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Director |
– • – |
2021-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
78,750 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Director |
– • – |
2020-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
68,750 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Director |
– • – |
2019-06-25 |
4 |
A |
$0.00 |
$0 |
D/D |
3,750 |
61,250 |
0 |
- |
|
| KALA |
Kala Pharmaceuticals, Inc... |
Director |
– • – |
2019-05-30 |
4 |
B |
$5.42 |
$27,100 |
D/D |
5,000 |
8,240 |
2.39 |
- |
|
| KALA |
Kala Pharmaceuticals, Inc... |
Director |
– • – |
2017-07-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,240 |
|
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
CEO |
• • – |
2016-05-13 |
4 |
B |
$3.26 |
$33,272 |
D/D |
10,206 |
50,000 |
2.81 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Intermin CEO |
• • – |
2015-05-19 |
4 |
B |
$0.00 |
$0 |
D/D |
35,400 |
39,794 |
2.73 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Director |
– • – |
2011-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
4,394 |
4,394 |
0 |
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
